Web Content Display Web Content Display

Contractor Profile
Contractor Profile
Contractor Profile

The Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau (the Hospital's Healthcare Management Foundation) forms part of the public sector, with the status of a contracting authority but not a public administration. This subjective status means that the Foundation is subject to the application of the Consolidated Text of the Public Sector Contracting Act. In accordance with Article 191 of this Act, the Hospital's Healthcare Management Foundation has approved Internal Contracting Guidelines that regulate the contracting procedures that are not subject to standardized regulation, with the aim of ensuring that the principles of disclosure, concurrence, transparency, confidentiality, equality and non-discrimination are upheld, and awarding the contract to this most financially beneficial tender.

Its contractor profile is listed on the Public Contract Service Platform of the Catalan Government, which includes all of the contractual activity of the Hospital's Healthcare Management Foundation, along with other information of interest to tenderers: Internal Contracting Guidelines, Contracting Office and the relevant contact details.

The following links also contain information on the contractual activity of the Hospital's Healthcare Management Foundation: the transparency website of the Fundació de Gestió Sanitària, Contracting Supervision and Assessment Office, Public Contract Register and the Catalan Tribunal of Public Sector Contracts.

 

LINKS:

Public Contract Service Platform of the Catalan Government

Service for notification of administrative acts and electronic communications (e-NOTUM)

Transparency website of the Fundació de Gestió Sanitària

Contracting Supervision and Assessment Office

Public Contract Register

 

Information on subsidized public procurement

 

European Regional Development Fund of the European Union

 

                                                                                               

 

Innovation is one of the main pillars of the Europe 2020 Strategy (EE2020) for smart, sustainable and inclusive growth. Within the framework of the EE2020, the European Regional Development Fund (ERDF) is run by the European Union as a source of financing for regions.

At a worldwide level, lung cancer is an illness with one of the highest incidence and a low survival rate due to patients being diagnosed at advanced stages of the disease. Currently, the prevention and detection of this disease, diagnostic precision and different potential treatments for lung cancer are priority objectives of health programs in most countries around the world.


The Hospital de Sant Pau is proposing a new diagnostic approach for patients with suspected lung cancer using minimally invasive techniques that improve the diagnostic performance of such patients within a model of coordination, joint responsibility and sharing risk between the hospital and the industry. Incorporating electromagnetic navigation bronchoscopy will enable us to respond to currently unresolved clinical situations and improve the management of patients with peripheral lung lesions that need accurate diagnosis.

Co-financed 50% by the European Regional Development Fund of the European Union within the framework of the Catalan ERDF Operational Program 2014-2020, the implementation of this project will improve the performance and reduce the complications of diagnosis, as well as facilitating the decision-making process for health professionals in this field, generating an overall financial saving and improving patient quality and safety.

  • Information on the ERDF 

 

Reinforcing the capacity to respond to the Covid-19 crisis implemented by CatSalut (Catalan Health Service)

 

                                                                                                                                              

 

Catalonia and the Member States have been uniquely affected by the consequences of Covid-19, which has triggered a public health crisis with huge economic and social impact. Huge levels of unplanned spending are required to reinforce the capacity of the health system, as well as for equipping society with the tools it needs to tackle the pandemic. The contribution of European funding is essential for overcoming the health and socioeconomic situation caused by the impact of Covid-19.

 

Horizon Program 2020

 

                                                                                                                                                 

 

Since 2008, the European Commission has been providing support through its innovation financing programs and by creating networks of public procurers at a European level to foster innovation and the exchange of good practices, as well as promoting cross-border public procurement.

Horizon 2020, the European Union's largest financing program for research and innovation in the period 2014-2020, funds the preparation and execution of cross-border public innovation procurement projects through its calls for applications.

Since 2015, the Health Management Foundation of the Hospital de la Santa Creu i Sant Pau has participated in European public innovation procurement projects:

Firstly, within the framework of the StopandGO Project, in 2016, the Foundation bid for a new treatment approach for patients with arrhythmia who require an implanted automatic defibrillator that, through a shared risk service contact and on a pay-for-performance basis, implements remote monitoring technologies that improve patient safety and comfort.

This project has received various accolades for management innovation at an international level, such as the Silver Economy Awards.

The Foundation currently heads the group of procurers that form the Ritmocore project, which aims to implement a comprehensive, integrated management service for patients with arrhythmia who require a pacemaker, covering the entire lifecycle of the treatment of these patients, as well as enhancing their empowerment and the coordination with primary care. The Health Management Foundation of the Hospital de la Santa Creu i Sant Pau procures services through the group of four procurers involved in the project, which includes the Hospital Universitari de Bellvitge, the Hospital Universitari Mútua de Terrassa and the Liverpool Heart and Chest Hospital.

The Ritmocore project is financed by the Horizon 2020 research and innovation program through the grant agreement no. 727796.

 

 

European Regional Development Fund of the European Union

 

                                                                                               

 

                      

Innovation is one of the main pillars of the Europe 2020 Strategy (EE2020) for smart, sustainable and inclusive growth. Within the framework of the EE2020, the European Regional Development Fund (ERDF) is run by the European Union as a source of financing for regions. The initiatives financed through the ERDF within the period 2014-2020 have to be aligned with the research and innovation strategies for smart specialisation strategy (RIS3) of each European region. One of the instruments of Catalonia's research and innovation strategies for smart specialisation strategy (RIS3CAT) is the RIS3CAT Public Innovation Procurement Program, which aims to ensure that the Public Administration is an active agent in the Catalan innovation system by co-financing the Catalan ERDF Operational Program 2014-2020 (PO ERDF Catalunya 2014-2020).

Healthcare is one of the key focus areas of the RIS3CAT Public Innovation Procurement Program. Therefore, with the objective of stimulating the implementation of public innovation procurement in the health sector, CatSalut is issuing a line of grants for public innovation procurement projects run by organizations that own centres that form part of the comprehensive public health service of Catalonia (Resolution SLT/1913/2017).

The Health Management Foundation of the Hospital de la Santa Creu i Sant Pau is one of the institutions that, within the framework of this line of grants, will conduct a project focusing on a diagnostic and therapeutic approach to lung cancer in undiagnosed patients through neuronavigation. This project aims to facilitate the study and monitoring of pulmonary nodules that are not currently diagnosed due to the complexity of obtaining samples of lung tissue, as well as advancing research and knowledge in this field.